Healthcare & Life Sciences

Angiocrine Bioscience

United States

series-b

Stage

About

Angiocrine Bioscience is a clinical stage biotechnology company that develops cell therapies targeting endothelial cells to treat hematologic diseases and cancer.

Explore Angiocrine Bioscience's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.